The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market:
https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-and-asthma-devices-global-market-report
According to The Business Research Company’s Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2024, The chronic obstructive pulmonary disease (COPD) and asthma devices market size has grown strongly in recent years. It will grow from $42.49 billion in 2023 to $44.95 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to growth in the elderly population, increasing incidence of allergies, increasing government initiatives, rise in clinical research and trials, and rise in urbanization.
The chronic obstructive pulmonary disease (COPD) and asthma devices market size is expected to see strong growth in the next few years. It will grow to $57.08 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to rising occurrences of respiratory diseases, rising smoking of cigarettes, rising environmental pollution levels and breathing problems, growing prevalence of respiratory diseases, growing healthcare expenditure, and rising portability of drug delivery devices. Major trends in the forecast period include technological advancements, integration of smart technology, personalized medicine, adoption of biologics, and wearable respiratory monitors.
The growing prevalence of respiratory diseases is expected to propel the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices market going forward. Respiratory diseases encompass many conditions affecting the lungs and respiratory systems, such as asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, impacting breathing and overall respiratory function. The growing prevalence of respiratory diseases is due to increasing air pollution levels, changing climate patterns affecting allergens and pathogens, and lifestyle habits such as smoking that compromise respiratory health. COPD and asthma devices play a crucial role in the comprehensive management and treatment of respiratory diseases, supporting patients to achieve better respiratory health and enhance their overall well-being. For instance, in March 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, chronic obstructive pulmonary disease (COPD) ranked as the third leading cause of death globally, resulting in approximately 3.23 million fatalities. Further, nearly 90% of these deaths in individuals under 70 years old occurred in low- and middle-income countries (LMICs). Therefore, the growing prevalence of respiratory diseases drives the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices markets.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
The chronic obstructive pulmonary disease (COPD) and asthma devices market covered in this report is segmented –
1) By Type: Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
4) By End User: Pediatric, Adult, Geriatric
Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are focusing on developing innovative technologies, such as inhalation devices, to integrate digital health features for remote monitoring and personalized treatment management. Inhalation devices are medical devices used to administer medications directly into the lungs through inhalation. For instance, in May 2022, Alkem Laboratories, an India-based pharmaceutical company, introduced the Innohaler, a dry powder inhaler (DPI) device, to make life easier for people with asthma and COPD. The Innohaler boasts advanced breath-actuated technology, ensuring precise medication delivery with each inhalation, optimizing dosage accuracy, and reducing waste. Its ergonomic design promotes ease of use, featuring a user-friendly interface that simplifies operation for patients of all ages. The device incorporates a compact and portable build, enhancing convenience for on-the-go use and improving patient adherence to prescribed treatments.
The chronic obstructive pulmonary disease (copd) and asthma devices market report table of contents includes:
1. Executive Summary
2. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Characteristics
3. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Trends And Strategies
4. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market – Macro Economic Scenario
5. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Size and Growth
.
.
.
32. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Benchmarking
33. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
35. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
